Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Mussetti

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
Vox Sanguinis|August 3, 2023
Development of an in-house bone marrow collection kit: The Catalan bone marrow transplantation group experienceJesus Fernandez-Sojo, Elena Valdivia, Albert Esquirol, et al.
Transplantation and Cellular Therapy|December 28, 2022
Haploidentical Versus Matched Unrelated Donor Transplants Using Post-Transplantation Cyclophosphamide for LymphomasAlberto Mussetti, Abraham S Kanate, Tao Wang, et al.
American Journal of Hematology|August 11, 2025
CD19 CAR T-Cell Therapy for Primary Mediastinal Large B-Cell Lymphoma: A CIBMTR AnalysisJordan Gauthier, Kwang W Ahn, Jinalben Patel, et al.
Bone Marrow Transplantation|July 8, 2022
Leukocytapheresis variables and transit time for allogeneic cryopreserved hpc: better safe than sorryJesus Fernandez-Sojo, Roger Horton, Joan Cid, et al.
Transplantation|November 19, 2016
Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo OsseoMichele Malagola, Valeria Cancelli, Cristina Skert, et al.
British Journal of Haematology|April 22, 2020
Impact of type of reduced-intensity conditioning regimen on the outcomes of allogeneic haematopoietic cell transplantation in classical Hodgkin lymphomaSairah Ahmed, Nilanjan Ghosh, Kwang W Ahn, et al.
Transplantation and Cellular Therapy|September 2, 2023
Impact of SCHOLAR-1 Criteria on Chimeric Antigen Receptor T Cell Therapy Efficacy in Aggressive B Lymphoma: A Real-World GELTAMO/GETH StudyMariana Bastos-Oreiro, Antonio Gutierrez, Gloria Iacoboni, et al.
Bone Marrow Transplantation|May 13, 2026
Central nervous system complications after allogeneic haematopoietic cell transplantation: best practice recommendations from the EBMT practice harmonisation and guidelines committee on epidemiology, outcome and neuroimagingMartin Schmidt-Hieber, Roser Velasco, Olaf Penack, et al.
Frontiers in Immunology|August 1, 2022
Best Treatment Option for Patients With Refractory Aggressive B-Cell Lymphoma in the CAR-T Cell Era: Real-World Evidence From GELTAMO/GETH Spanish GroupsMariana Bastos-Oreiro, Antonio Gutierrez, Juan Luís Reguera, et al.
Bone Marrow Transplantation|April 17, 2025
The impact of ABO compatibility on allogeneic hematopoietic cell transplantation outcomes: a contemporary and comprehensive study from the transplant complications working party of the EBMTMustafa Güven, Christophe Peczynski, William Boreland, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Vox Sanguinis|August 3, 2023
Development of an in-house bone marrow collection kit: The Catalan bone marrow transplantation group experienceJesus Fernandez-Sojo, Elena Valdivia, Albert Esquirol, et al.
Transplantation and Cellular Therapy|December 28, 2022
Haploidentical Versus Matched Unrelated Donor Transplants Using Post-Transplantation Cyclophosphamide for LymphomasAlberto Mussetti, Abraham S Kanate, Tao Wang, et al.
American Journal of Hematology|August 11, 2025
CD19 CAR T-Cell Therapy for Primary Mediastinal Large B-Cell Lymphoma: A CIBMTR AnalysisJordan Gauthier, Kwang W Ahn, Jinalben Patel, et al.
Bone Marrow Transplantation|July 8, 2022
Leukocytapheresis variables and transit time for allogeneic cryopreserved hpc: better safe than sorryJesus Fernandez-Sojo, Roger Horton, Joan Cid, et al.
Transplantation|November 19, 2016
Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo OsseoMichele Malagola, Valeria Cancelli, Cristina Skert, et al.
British Journal of Haematology|April 22, 2020
Impact of type of reduced-intensity conditioning regimen on the outcomes of allogeneic haematopoietic cell transplantation in classical Hodgkin lymphomaSairah Ahmed, Nilanjan Ghosh, Kwang W Ahn, et al.
Transplantation and Cellular Therapy|September 2, 2023
Impact of SCHOLAR-1 Criteria on Chimeric Antigen Receptor T Cell Therapy Efficacy in Aggressive B Lymphoma: A Real-World GELTAMO/GETH StudyMariana Bastos-Oreiro, Antonio Gutierrez, Gloria Iacoboni, et al.
Bone Marrow Transplantation|May 13, 2026
Central nervous system complications after allogeneic haematopoietic cell transplantation: best practice recommendations from the EBMT practice harmonisation and guidelines committee on epidemiology, outcome and neuroimagingMartin Schmidt-Hieber, Roser Velasco, Olaf Penack, et al.
Frontiers in Immunology|August 1, 2022
Best Treatment Option for Patients With Refractory Aggressive B-Cell Lymphoma in the CAR-T Cell Era: Real-World Evidence From GELTAMO/GETH Spanish GroupsMariana Bastos-Oreiro, Antonio Gutierrez, Juan Luís Reguera, et al.
Bone Marrow Transplantation|April 17, 2025
The impact of ABO compatibility on allogeneic hematopoietic cell transplantation outcomes: a contemporary and comprehensive study from the transplant complications working party of the EBMTMustafa Güven, Christophe Peczynski, William Boreland, et al.
Pageof 10